Adviser Investments »

Crinetics Pharmaceuticals In shares owned by Adviser Investments

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Adviser Investments from 13F filings

Historical chart of Adviser Investments investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Adviser Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Adviser Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $291k 5.7k 51.10
2024-06-30 $255k 5.7k 44.79
2024-03-31 $267k 5.7k 46.81
2023-12-31 $203k 5.7k 35.58

More positions owned by Adviser Investments

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Spdr Ser Tr Portfolio Crport (SPBO)
Ishares Tr National Mun Etf (MUB)
Ishares Tr Mbs Etf (MBB)
Apple (AAPL)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core S&p500 Etf (IVV)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Vanguard Index Fds Sm Cp Val Etf (VBR)

View all positions for Adviser Investments

Top funds holding Crinetics Pharmaceuticals In

BlackRock
BlackRock
Driehaus Capital Management
T. Rowe Price Associates
Vanguard Group
EcoR1 Capital
State Street Corporation
Jennison Associates
Paradigm Biocapital Advisors
Henderson Group
Point72 Asset Management
Geode Capital Management
Franklin Resources
Cormorant Asset Management
Siren

View all funds holding Crinetics Pharmaceuticals In